Sera Prognostics, Inc. (SERA)
2.05
-0.04
(-1.91%)
USD |
NASDAQ |
Oct 05, 15:47
Sera Prognostics Max Drawdown (5Y) : 91.10% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 91.10% |
| August 31, 2026 | 91.10% |
| July 31, 2026 | 91.10% |
| June 30, 2026 | 91.10% |
| May 31, 2026 | 91.10% |
| April 30, 2026 | 91.10% |
| March 31, 2026 | 91.10% |
| Date | Value |
|---|---|
| February 28, 2026 | 91.10% |
| January 31, 2026 | 91.10% |
| December 31, 2025 | 91.10% |
| November 30, 2025 | 91.10% |
| October 31, 2025 | 91.10% |
| September 30, 2025 | 91.10% |
| August 31, 2025 | 91.10% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Myriad Genetics, Inc. | 92.20% |
| BioRestorative Therapies, Inc. | 99.99% |
| CareDx, Inc. | 94.87% |
| Natera, Inc. | 77.74% |
| Exagen, Inc. | 95.22% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -42.77 |
| Beta (5Y) | 1.058 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 139.8% |
| Historical Sharpe Ratio (5Y) | -0.2302 |
| Historical Sortino (5Y) | -0.7542 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.15% |